Whilst the clinical features of GRN-, MAPT- and C9orf72-associated FTD largely overlap, the underlying molecular processes leading to that phenotypic endpoint are fundamentally different (Lashley et al., 2015). The gene discussed is MAPT; the disease is frontotemporal dementia.